| # | Drug | Count |
|---|---|---|
| 0 | AMBRISENTAN | 2 |
| 1 | AMPHOTERICIN B | 2 |
| 2 | DIAZEPAM | 2 |
| 3 | DIAZEPAM ORAL | 2 |
| 4 | DIAZEPAM ORAL SOLUTION (CONCENTRATE) | 2 |
| 5 | FUROSEMIDE | 2 |
| 6 | LEVETIRACETAM | 2 |
| 7 | PHENOBARBITAL | 2 |
| 8 | PREGABALIN | 2 |
| 9 | SILDENAFIL CITRATE | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ORPHENADRINE CITRATE | 1 | 0.0016 |
| 1 | ZILEUTON | 1 | 0.0015 |
| 2 | LOMUSTINE | 1 | 0.0004 |
| 3 | GALSULFASE | 1 | 0.0003 |
| 4 | CARMUSTINE | 1 | 0.0002 |
| 5 | PANCRELIPASE LIPASE, PANCRELIPASE PROTEASE, PANCRELIPASE AMYLASE | 1 | 0.0002 |
| 6 | AMPHOTERICIN B | 2 | 0.0002 |
| 7 | MICAFUNGIN SODIUM | 1 | 0.0002 |
| 8 | TERBINAFINE HYDROCHLORIDE TABLET | 1 | 0.0001 |
| 9 | PHENOBARBITAL | 2 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Alkylating Drug [EPC] | 4 |
| 1 | Azole Antifungal [EPC] | 2 |
| 2 | Benzodiazepine [EPC] | 2 |
| 3 | Endothelin Receptor Antagonist [EPC] | 2 |
| 4 | Factor Xa Inhibitor [EPC] | 2 |
| 5 | Janus Kinase Inhibitor [EPC] | 2 |
| 6 | Kinase Inhibitor [EPC] | 2 |
| 7 | Lipid-based Polyene Antifungal [EPC] | 2 |
| 8 | Loop Diuretic [EPC] | 2 |
| 9 | Phosphodiesterase 5 Inhibitor [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | 5-Lipoxygenase Inhibitor [EPC] | 1 | 0.0015 |
| 1 | Lipid-based Polyene Antifungal [EPC] | 2 | 0.0002 |
| 2 | Allylamine Antifungal [EPC] | 1 | 0.0001 |
| 3 | Echinocandin Antifungal [EPC] | 1 | 0.0001 |
| 4 | Calcitonin Gene-related Peptide Antagonist [EPC] | 1 | 0.0001 |
| 5 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 1 | 0.0001 |
| 6 | Polyene Antifungal [EPC] | 2 | 0.0000 |
| 7 | Typical Antipsychotic [EPC] | 1 | 0.0000 |
| 8 | Alkylating Drug [EPC] | 4 | 0.0000 |
| 9 | Phosphodiesterase 5 Inhibitor [EPC] | 2 | 0.0000 |